Autologous Cord Blood Therapy for Infantile Cerebral Palsy: From Bench to Bedside
Figure 11
The success of autologous cord blood treatment in children with CP caused by hypoxic-ischemic encephalopathy depends on age. Recalculated from Lee et al., Table 1 [45], (HIE, 8/20, 65.2 ± 23.1 SD months, versus 37.3 ± 6.0 SD months, , **, Chi-Square-test). The paper from which the data for recalculation were derived is available online at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3369209/.
